-
·
Announcing the 5th edition of the GMP for ATMP Summer School
From October 14–16 2026, the 5th edition of the GMP for ATMP Summer School will take place at the Science Park University of Antwerp. Once again, 40 students from the Antwerp university colleges will have the opportunity to participate in this unique training programme, combining both theory and hands-on practice. With this initiative, at.las continues…
-
·
Connect with at.las ATMP at Knowledge for Growth!
Curious about opportunities in the cell and gene therapy domain? Connect with our alliance manager Eva Lion who will be representing at.las ATMP at the POM Antwerpen booth #69 at #KFG2026 this week!
-
·
A New Step Forward in Multiple Sclerosis Research: Launch of the LUMINA-MS Clinical Trial
On April 20, 2026, an important milestone was reached in the field of multiple sclerosis research. The Belgian Federal Agency for Medicines and Health Products (FAMHP) and the Spanish Agencia Española de Medicamentos y Productos Sanitarios granted authorization for a Phase IIa clinical trial sponsored by the University Hospital Antwerp (UZA). This study will evaluate…
-
·
GDP Training for ATMP Developers and Manufacturers on 28 april 2026
When ATMP developers or manufacturers ship pharmaceuticals, they must ensure that all employees involved have successfully completed GDP training. This requirement is mandated by Belgian legislation and is an important focus during inspections and audits. Therefore, we will host a dedicated GDP (Good Distribution Practice) training course specifically designed for ATMP organizations on 28 april…
-
·
Lecture Series/Advanced Therapeutics for Hearing Disorders on 21 april 2026
How do we translate molecular insights into real therapies for patients with hearing disorders? On April 21 at 16:00 (Antwerp Campus Drie Eiken, Auditorium O5), we welcome two speakers to explore cutting-edge delivery strategies and cellular mechanisms shaping the future of inner ear therapeutics: Prof. Dr. Athanasia Warnecke (Hannover Medical School, Germany) : Extracellular Vesicles…
-
·
Reviewed for you: Current state of ATMP enabling T cell epitope discovery for the development of antigen-specific therapies for autoimmune disorders
If you are interested in autoreactive T-cell epitopes and the methods used to identify autoreactive T cells, this review is definitely worth your time. The article highlights how ATMPs are reshaping the way we approach autoimmune diseases. These therapies aim to precisely target immune responses, moving away from broad immunosuppression toward antigen-specific interventions. A central…
-
·
This was the GMP for ATMP Summer School 2025
Shaping Talent for the Therapies of Tomorrow From 7 to 9 October 2025, the fourth edition of the GMP for ATMP Summer School took place at the Science Park University of Antwerp in Niel. Organised by at.las, with the support of POM Antwerpen, the three-day programme welcomed 35 students in (bio)chemistry and laboratory techniques from…
